反応式
C(OC(=O)[N:7]([CH2:9][CH:10]([C:18]1[CH:23]=[CH:22][C:21]([Br:24])=[CH:20][CH:19]=1)[C:11]1[CH:16]=[CH:15][C:14]([OH:17])=[CH:13][CH:12]=1)[CH3:8])(C)(C)C.Cl[C:27]1[CH:32]=[N:31][CH:30]=[CH:29][N:28]=1.C([O-])([O-])=O.[K+].[K+]>CN(C)C=O>[Br:24][C:21]1[CH:20]=[CH:19][C:18]([CH:10]([C:11]2[CH:12]=[CH:13][C:14]([O:17][C:27]3[CH:32]=[N:31][CH:30]=[CH:29][N:28]=3)=[CH:15][CH:16]=2)[CH2:9][NH:7][CH3:8])=[CH:23][CH:22]=1参加物
実験手順
A solution of [2-(4-Bromo-phenyl)-2-(4-hydroxy-phenyl)-ethyl]-methyl-carbamic acid tert-butyl ester (125 mg, 0.31 mmol), 2-chloropyrazine (35.2 mg, 0.31 mmol) and K2CO3 (213 mg, 1.54 mmol) in dimethylformamide (8 ml) was heated to 100° C. for 17 hours. Upon cooling, the solvent was removed under reduced pressure and the residue was partitioned between ethyl acetate and saturated NaHCO3 solution. The organic layer was dried (MgSO4), filtered and concentrated. The crude product was then treated with saturated HCl in diethyl ether (15 ml) and stirred at room temperature for 72 hours. The solvent was then removed under reduced pressure and the crude product was purified by Phenomenex_Strata_SCX column chromatography eluting with methanol followed by 2N ammonia in methanol to afford the desired product (82 mg). LC/MS: (PS-B3) Rt 3.17 [M+H]+ 384.
後処理
- temperatureUpon cooling
- customthe solvent was removed under reduced pressure
- customthe residue was partitioned between ethyl acetate and saturated NaHCO3 solution
- dry with materialThe organic layer was dried (MgSO4)
- filtrationfiltered
- concentrationconcentrated
- additionThe crude product was then treated with saturated HCl in diethyl ether (15 ml)
- customThe solvent was then removed under reduced pressure
- customthe crude product was purified by Phenomenex_Strata_SCX column chromatography
- washeluting with methanol
出典と根拠
- ORDレコード
- ord-3c58d8d63c0c45d781ee96c62844aec0
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08541461B2
関連ノート
読み込み中…